You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Express Scripts
McKesson
AstraZeneca
Harvard Business School

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Details for Patent: 10,449,185

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,449,185 protect, and when does it expire?

Patent 10,449,185 protects NUPLAZID and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 10,449,185
Title:Formulations of pimavanserin
Abstract: Provided herein are capsules containing pimavanserin, processes for manufacturing said capsule, and pharmaceutical compositions containing pimavanserin.
Inventor(s): Tejwani; Ravi (Monmouth Junction, NJ), Abele; Stephen Edward (White Plains, NY), Vizzotti; Emanuel Joseph (Millburn, NJ)
Assignee: ACADIA Pharmaceuticals Inc. (San Diego, CA)
Application Number:16/363,378
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,449,185
Patent Claim Types:
see list of patent claims
Composition; Formulation; Delivery; Device; Dosage form;

Drugs Protected by US Patent 10,449,185

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acadia Pharms Inc NUPLAZID pimavanserin tartrate CAPSULE;ORAL 210793-001 Jun 28, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Harvard Business School
Moodys
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.